1. Diagnostic Value of SFRP1 as a Favorable Predictive and Prognostic Biomarker in Patients with Prostate Cancer
   Lei Zheng et al, 2015, PLOS ONE CrossRef
2. Wnt signalling pathway in bladder cancer
   Guanlin Wu et al, 2021, Cellular Signalling CrossRef
3. Regulation of metastasis of bladder cancer cells through the WNT signaling pathway
   Yiheng Du et al, 2015, Tumor Biology CrossRef
4. Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta‑analysis
   Jun Yu et al, 2019, Oncology Letters CrossRef
5. Hypomethylation agent decitabine restores drug sensitivity by depressing P-glycoprotein activity through MAPK signaling pathway
   Huihan Wang et al, 2017, Molecular and Cellular Biochemistry CrossRef
6. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial–mesenchymal transition
   H Quan et al, 2014, Oncogene CrossRef
7. SFRP1 decreases WNT-Mediated M2 macrophage marker expression in breast tissue
   Kelly J. Gregory et al, 2024, Cancer Immunology, Immunotherapy CrossRef
8. Canonical Wnt signaling in systemic sclerosis
   Christina Bergmann et al, 2016, Laboratory Investigation CrossRef
9. SFRP1 Promoter Methylation and Renal Carcinoma Risk: A Systematic Review and Meta-Analysis
   Shijie Mo et al, 2018, Journal of Nippon Medical School CrossRef
10. MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/β-Catenin signalling
    MingJun Shi et al, 2020, Bioscience Reports CrossRef
11. miR‐144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling
    Yuwen Guo et al, 2013, The FEBS Journal CrossRef
12. Retracted: Inhibition of microRNA‐940 suppresses the migration and invasion of human osteosarcoma cells through the secreted frizzled‐related protein 1–mediated Wnt/β‐catenin signaling pathway
    Zun‐Wen Lin et al, 2019, Journal of Cellular Biochemistry CrossRef
13. Epigenetics of SFRP1: The Dual Roles in Human Cancers
    Rashidah Baharudin et al, 2020, Cancers CrossRef
14. The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis
    Clara Dees et al, 2014, Annals of the Rheumatic Diseases CrossRef